NCT07385716Completed
Evaluation of the Effect of Time-Restricted Feeding and Mediterranean Diet Model in Women With Polycystic Ovary Syndrome
Source: ClinicalTrials.gov · Last updated 28 Apr 2026
Brief summary (registry, in English)
Currently, there is still insufficient data to support the long-term efficacy, safety, and health benefits of time-restricted feeding models in women diagnosed with Polycystic ovary syndrome (PCOS), and further studies are needed to test and validate the effects of long-term dietary management in PCOS. On the other hand, similarly, studies investigating the effects of the Mediterranean Diet on body composition and dietary intake in women with PCOS are limited. The primary aim of this research is to examine the effect of time-restricted feeding and the Mediterranean diet model on body composition and dietary intake in adult women diagnosed with PCOS. The secondary aim is to evaluate the effect of different dietary models on quality of life in women diagnosed with PCOS.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 55 (actual)
- First submitted
- 17 Jan 2026
- Start date
- 2 Jan 2026
- Primary completion date
- 30 Jan 2026
- Lead sponsor
- Selcuk University
- NCT number
- NCT07385716
What you commit to
- Study type: Interventional
- Participants enrolled: 55
- From 2 Jan 2026 to the primary completion date, 30 Jan 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Use of insulin or oral antidiabetic drugs,
- Use of medication affecting carbohydrate or lipid metabolism in the last 6 months (oral contraceptive pills, insulin sensitizers, antiepileptics, antipsychotics, statins and fish oil)
Other illness
- Combination of other endocrine etiological disorders according to Rotterdam criteria (congenital adrenal hyperplasia, Cushing syndrome, androgen-secreting tumors, hyperprolactinemia, thyroid, adrenal and other endocrine disorders)
- Combination of cardiovascular and cerebrovascular diseases, hematological disorders, hepatic and renal failure and other serious diseases
- Liver and kidney disease
- A psychiatric condition diagnosed by a physician It has been determined as a disease state.
Other
- Being pregnant and lactating
- Low compliance and non-compliance with treatment during the intervention (individuals with less than 80% compliance will be excluded from the study)
- Preparation for pregnancy status during the dietary intervention
- Women with pacemakers or defibrillators implanted due to the theoretical possibility of interference with device activity due to the current field caused by impedance measurements
Who the study is looking for
- Being between 20-49 years of age
- Having been diagnosed with PCOS by a specialist according to Rotterdam criteria
- Having a BMI between 25-35 kg/m2
- Not having any conditions that impair reality testing and cognitive functions, preventing interviews or completing scales
- Being literature
- Having signed the informed consent form by agreeing to participate in the study.
Age in the registry: 20 years to 49 years · Sex: Female · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Healthy Life Center Coordinator of this site? Confirm its status | Konya | Turkey (Türkiye) | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.